Zhejiang Anglikang Pharmaceutical Hits Day High with 10% Surge

Zhejiang Anglikang Pharmaceutical Co. has experienced a significant surge in its stock price, gaining 10.0% on May 21, 2026. The stock reached an intraday high of CNY 45.65, showcasing its strong performance in the pharmaceuticals and biotechnology sector. Over the past year, Zhejiang Anglikang has delivered impressive returns of 212.67%, significantly outperforming the China Shanghai Composite, which only saw a 20.36% increase during the same period. The company's year-to-date performance stands at 36.19%, further highlighting its robust market position. Despite these gains, the company has faced challenges, including a decline in profits by 2.2% over the past year. Key financial metrics indicate a return on equity of 9.14% and a price-to-book ratio of 3.86, suggesting a relatively high valuation. Additionally, the company has a dividend yield of 0.57%, which may appeal to certain investors. Overall, Zhejiang Anglikang's recent stock activity reflects its strong market performance, even as it navigates some underlying financial pressures.